新聞

新聞

醜聞!禁上游泳課、逼退學 國防大學爆歧視愛滋生

國防大學爆發歧視愛滋學生「醜聞」!一名大四即將畢業的學生阿立(化名)一次健康檢查中,無意被學校得知感染了愛滋病毒,沒想到學校竟用盡一切手段,禁止其上游泳課、要求餐盤衣服分開清洗,甚至周周約談該生,硬逼其退學,衛福部疾管署今(26)天怒摃國防大學,將上訴到底要求撤銷退學處分。

台北高等行政法院是在日前就國防大學不服衛福部為阿立爭取就學權益一案之上,判衛福部敗訴,疾管署長郭旭崧今天親自召開記者會,強調校方做法就是實質的歧視,將據理力爭,上訴到底。

郭旭崧說,法院一審判決並未否認學校有歧視行為,卻認定衛福部沒有推翻其他行政機關歧視行為的權力,明顯忽略了「人類免疫缺乏病毒傳染防治及感染者權益保障條例」的立法精神,對疾管署執行愛滋人權保障是很大的挫敗,此例一開,將造成不可收拾的局面,疾管署不可能就此罷手。

愛滋病感染者權益促進會秘書長林宜慧說,學校不只周周由不同的師長無故約談阿立,勸其「身體不好要不要回家休養」、「同學覺得你很奇怪,要不要自願離校」等,甚至威脅阿立若不自動退學,就要將病情告知家人,最後就以抓到阿立違規為由,以態度不佳、頂撞師長等連續記過退學。

台灣還是在發生歧視愛滋事件!林宜慧強調,雖然阿立經向衛福部申訴後,得到衛福部要求學校應恢復就學機會或雙方和解的正面回應,沒想到如今法院竟然撤銷衛福部要求學校改善的處分,令人痛心。

郭旭崧強調,疾管署對於判決感到相當遺憾,也對阿立的遭遇感到痛心以及不捨,將會再上訴至最高行政法院,也呼籲國防大學能夠善意回應,以關懷取代歧視,從心接受愛滋感染者。並提醒愛滋感染者若受到各式不公平待遇或歧視時,可尋求衛生局人員的協助積極爭取自身就學、就業、就醫等合法權益。

記者陳鈞凱/台北報導
2016.04.26 / 17:31

驚!愛滋拖到發病 上班族「不藥」最多


感染愛滋,竟有人能拖就拖,遲遲不願意用藥!台灣愛滋病學會今(22)天表示,觀察發現國內有許多感染者抱持「能拖就拖,到有症狀時才願意用藥」的心態,增加健康與傳染他人風險。而感染科醫師臨床經驗,這類感染者多半都是年輕、剛出社會的上班族,除了過度懼怕副作用,就是怕用藥露餡遭歧視。

台灣愛滋病學會今天召開記者會,強調以「治療作為預防」的防治措施已是世界趨勢,呼籲確診感染者提早用藥,可免除發病恐懼、大幅降低醫療負擔,也能達到最好的預防傳染效果。

台大醫院感染科兼任主治醫師羅一鈞表示,門診的確有不少感染者,硬是拖到都發病了,才肯用藥,追根究底問起來,一部人是錯誤迷思或聽信網路傳言,懼怕用藥副作用,擔心一輩子用藥,傷肝傷腎。

還有一部分人不肯用藥的原因是怕病情曝光,羅一鈞說,又以上班族群為主,尤其是與家人同住者,擔心用藥起紅疹引人矚目,或藥袋不小心洩漏秘密,乾脆不接受藥物治療,拖到免疫力持續下降,出現皮蛇、皮膚炎等症狀甚至發病才肯回頭診治。

台灣愛滋病學會理事長林錫勳強調,醫界推估,至少有4成感染者經確診後未接受治療,擴大治療所有愛滋病毒感染者,及以治療作為預防的防治措施已是世界趨勢,就公衛角度,讓感染者接受服藥治療,對於控制愛滋病毒傳播的效果,更優於「單純使用保險套」,尤其在感染初期,利用藥物可有效抑制病毒量,使傳染風險降到最低,保護自己也保護他人。

台大醫院感染科主治醫師洪健清從事愛滋照護工作逾20年,觀察到過去許多感染者寧可冒著發病或傳染給伴侶的危險,也不願意服藥,主因是受到藥物副作用大的影響,然而新的抗病毒藥物已演進到只要一天吃一顆、藥物耐受性佳,也不會有黃疸、腹瀉等嚴重副作用。

洪健清說,未提前用藥的患者,一旦發病可能會面臨呼吸衰竭,而需住進加護病房進行插管治療等;反之,穩定服藥的感染者可維持多年不發病,存活壽命跟一般人無異,千萬不要因小失大。

作者記者陳鈞凱/台北報導 | NOWnews – 2016年1月22日 下午2:59

2015年愛滋病感染者第二季增179名

衞生署衞生防護中心於本年第二季接獲共179宗感染愛滋病病毒(人類免疫力缺乏病毒)新增個案。

衞生防護中心顧問醫生(特別預防計劃)黃加慶昨日表示,如沒有接受治療,約半數的愛滋病病毒感染者會於10年內病發為愛滋病患者。

在今季的179宗愛滋病病毒感染個案中,100人透過同性或雙性性接觸受感染,32人透過異性性接觸受感染,3人透過注射毒品受感染,1人透過母嬰傳播受感染,而餘下43名感染者的傳播途徑因資料不足而暫時未能確定。在179名受愛滋病病毒感染人士中,155名為男性,24名為女性。

確診呈報1607宗

本年第二季的新診斷個案的三個主要呈報來源分別是公立醫院及診所(66宗)、私家醫院及診所(34宗)及衞生署社會衞生科診所(31宗)。此外,季內共有31宗愛滋病新增個案,其中45%是透過同性或雙性性接觸受感染,而45% 是透過異性性接觸受感染。自1985年以來,本港愛滋病確診呈報個案累積有1,607宗。

在今年第一季的新呈報個案中,有113名感染者(63%)已到衞生署或醫院管理局轄下的愛滋病專科服務接受治理。

黃加慶在記者會上說:「曾進行不安全性行為的人士應及早接受愛滋病病毒抗體測試。他們可致電衞生署愛滋熱線(2780 2211),預約接受免費、不記名及保密的愛滋病病毒抗體測試。」

Researchers create treatment to stop HIV spreading in couples

Researchers create treatment to stop HIV spreading in couples

Justin Quesinberry, WNCN StaffPublished: July 21, 2015, 8:26 pm


CHAPEL HILL, NC (WNCN) — UNC researchers are making international headlines in the fight against HIV.

On Monday they announced that antiretroviral treatment could stop the spread of the virus in couples nearly every time.

In 2005, 1,763 couples at 13 sites in nine countries enrolled in a clinical trial in which one person in the couple was infected with HIV and one was not.

The question was, could drugs prevent the infected person from transferring HIV to their partner?

A decade later and the results are in.

“The result was 93 percent protection.” Said J. Victor Garcia, UNC Professor of Medicine. “In prevention studies, nothing has ever been this good. Nothing goes even close.”

Garcia did not work on the study alongside his UNC colleagues who did.

Dr. Myron Cohen, Director Of The Institute For Global Health And Infectious Diseases at UNC-Chapel Hill was the principal investigator for the study.

While Dr. Cohen is in Canada presenting their findings at the International AIDS Society Conference On HIV Pathogenesis, Treatment And Prevention, Garcia  talked with WNCN about the impact.

“We can reduce the transmission of the virus in a proportion that was unimaginable before. Over 93 percent reduction in transmission. Those numbers are staggering. This is a miracle of medicine. Nothing like this has ever been seen before and have it originate in a place like the University of North Carolina, is something that makes us not only very, very proud ourselves because we’re part of the community, but also part of the entire state and world. We’re contributing to the health of the world,” said Garcia.

The infected person must take the drug treatment daily for it to be effective.

“Of the very few cases in which patients were observed to transmit the virus to their partners,  in those few cases people would either ignore taking their drugs or actually had developed a resistance to the drugs,” Dr. Garcia said.

The majority of the couples, 97 percent, were heterosexual.

In some cases, couples even conceived children.

“This will prevent many, many people from acquiring HIV infection and it will allow people in couples to actually live a very carefree life as far as their infection is concerned,” said Garcia.

Initial results were released in 2011.

“But it had to continue for five more years until today to actually demonstrate that the duration of the benefits was going to be long lasting and it proved true,” said Garcia.

Despite the high success rate, researchers say there remains a risk of transmission in couples that use the treatment.

The study, called HPTN 052, was funded primarily by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

傳媒普遍沒有向讀者提供PrEP的詳細資料

今年五月,奧地一間雜誌公司以摻有HIV陽性血液的墨水印製雜誌,成功引起全球關注,有效宣揚反標籤訊息。

可是發行人Wiehl於報導其中一段說話廣泛被不同傳媒引用:「你可以親吻任何一個HIV感染者,或是當感染者有用藥物作良好控制,而且你也有使用暴露前預防性投藥(PrEP)的話,你甚至可以和感染者無套做愛。」

而傳媒普遍沒有向讀者提供PrEP的詳細資料,如服藥風險和方法,很大可能誤導公眾以為只要服用PeEP便可跟untetectable的感染者進行無套性交。


Centers for Disease Control and Prevention(the Department of Health and Human Services in America)said:

You should not stop using condoms because you are taking PrEP. If PrEP is taken daily, it offers a lot of protection against HIV infection, but not 100%. Condoms also offer a lot of protection against HIV infection if they are used correctly every time you have sex, but not 100%. PrEP medicines don’t give you any protection from other infections you can get during sex (like gonorrhea, chlamydia, and hepatitis), but condoms do.

So you will get the most protection from HIV and other sexually transmitted diseases if you consistently take PrEP medicine and consistently use condoms during sex.

http://www.cdc.gov/hiv/basics/prep.html

 
 
您目前位置:Home 資訊天地 新聞 news